Comment on Niewczas et al. Circulating Modified Metabolites and a Risk of ESRD in Patients With Type 1 Diabetes and Chronic Kidney Disease. Diabetes Care 2017;40:383–390
2018 ◽
Vol 6
(1)
◽
pp. e000521
◽
Keyword(s):
Keyword(s):
Keyword(s):